Shoji J, Lew SQ. The use of rituximab and bendamustine in treating chronic lymphocytic leukaemia (CLL) in end-stage renal disease (ESRD). BMJ Case Rep. Published online: 2 May 2013. doi:10.1136/bcr-2013-009637.
There is an error in the ‘Treatment’ section of this paper. The correction is ‘The patient was treated with… rituximab 375 mg/m2 on day 1…’ and not ‘3.75 mg/m2’ as currently stated.
